Empowered Patient Podcast

Manish Arora, the CEO and Co-Founder of LinusBio, is developing technologies to measure and analyze the exposome which reveals lifelong exposure to environmental factors. Their platform measures molecular signatures in hair samples for early detection and diagnosis of conditions such as autism, where traditional observational methods can be limited. LinusBio is also exploring the use of the platform for other neurological conditions like ADHD and ALS and gaining a better understanding of the role of environmental exposures in the development of diseases. The company has received Breakthrough Designation from the FDA for its autism biomarker to bring this technology to patients.   Manish explains, "Our genes are static. So if I were to measure your genes when you were a child, or measure them today, I would get the same answer pretty much. Whereas your exposome changes all the time and so does your body's reaction to it. Let me give you a very simple example. A cup of espresso in the morning has a very differ